- Research works
- 91 ▲ 343% vs 2013–17
- Citations
- 794 8.7 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 65% world 28%
Not ranked overall: European Federation of Pharmaceutical Industries and Associations is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 23.2×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 23.2×
- Economics, Econometrics and Finance 9.3×
- Immunology and Microbiology 4.0×
- Health Professions 3.9×
- Veterinary 2.6×
- Nursing 2.6×
- Medicine 1.8×
- Chemical Engineering 0.7×
- Engineering 0.6×
- Environmental Science 0.5×
- Biochemistry, Genetics and Molecular Biology 0.5×
- Business, Management and Accounting 0.4×
- Chemistry 0.4×
- Mathematics 0.4×
- Materials Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Computer Science 0.0×
Who are the top researchers at European Federation of Pharmaceutical Industries and Associations?
Ranked on the composite score, Kirsty Reid and Stephanie Kohl lead among researchers whose main affiliation is European Federation of Pharmaceutical Industries and Associations.
- 1 Kirsty Reid Belgium · #931,525 worldwide 12 citations · 15 works
- 2 Stephanie Kohl Belgium · #1,069,185 worldwide 30 citations · 20 works
Which keywords describe research at European Federation of Pharmaceutical Industries and Associations?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inappropriate Medication Use, Polypharmacy, Adverse Drug Reactions, Innovation, Drug Development Costs, Generic Drugs, Clinical Pharmacy and Pharmaceutical Care.
- Private R&D
- Health Workforce
- Primary Care
- Medication Adherence
- Fuel Consumption
- Quality of Life
- Cost-effectiveness Analysis
- Health Biotechnology
- Public Health
- Pharmaceutical Care
- Generic Drugs
- Innovation
- Polypharmacy
- Inappropriate Medication Use
- Adverse Drug Reactions
- Drug Development Costs
- Clinical Pharmacy
- Clinical Trials
- Global Collaboration
- Epidemiology
- Drug Development
- Eco-Driving
- Genomic Studies
- Patient Safety
- Electronic Health Records
- Nurse Practitioners
- R&D Subsidies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Inappropriate Medication Use3▲ 271×1 topic
- Polypharmacy3▲ 271×1 topic
- Adverse Drug Reactions3▲ 193×2 topics
- Innovation3▲ 9.6×4 topics
- Drug Development Costs3▲ 380×1 topic
- Generic Drugs3▲ 380×1 topic
- Clinical Pharmacy2▲ 680×1 topic
- Pharmaceutical Care2▲ 680×1 topic
- Clinical Trials2▲ 11×4 topics
- Public Health2▲ 4.4×6 topics
- Global Collaboration2▲ 182×1 topic
- Health Biotechnology2▲ 397×1 topic
- Epidemiology2▲ 1.47×8 topics
- Cost-effectiveness Analysis1▲ 62×1 topic
- Drug Development1▲ 60×2 topics
- Quality of Life1▲ 3.7×1 topic
- Eco-Driving1▲ 98×1 topic
- Fuel Consumption1▲ 68×1 topic
- Genomic Studies1▲ 76×2 topics
- Medication Adherence1▲ 75×2 topics
- Patient Safety1▲ 29×2 topics
- Primary Care1▲ 11×3 topics
- Electronic Health Records1▲ 41×2 topics
- Health Workforce1▲ 89×1 topic
- Nurse Practitioners1▲ 284×1 topic
- Private R&D1▲ 194×1 topic
- R&D Subsidies1▲ 194×1 topic
Which research topics does European Federation of Pharmaceutical Industries and Associations publish most on?
By volume in 2022–2025: Pharmaceutical Practices and Patient Outcomes, Pharmaceutical Economics and Policy, Pharmacy and Medical Practices and Biotechnology and Related Fields.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmaceutical Practices and Patient Outcomes Geriatrics and Gerontology 3 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
- 3 Pharmacy and Medical Practices Pharmacology 2 works
- 4 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 2 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 6 Vehicle emissions and performance Automotive Engineering 1 works
- 7 Nursing Roles and Practices General Health Professions 1 works
- 8 Innovation Policy and R&D Economics and Econometrics 1 works
- 9 Biomedical Ethics and Regulation Physiology 1 works
- 10 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has European Federation of Pharmaceutical Industries and Associations's research output changed?
Output in 2018–2022 was 343% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Brussels
- Vrije Universiteit Brussel
- Université Libre de Bruxelles
- Cliniques Universitaires Saint-Luc
- Erasmus Hospital
- European Commission
- UCLouvain Saint-Louis Brussels
- European Union of Medical Specialists
- European Union
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.